.Pharmacolibrary.Drugs.V_Various.V08C_MagneticResonanceImagingContrastMedia.V08CA10_GadoxeticAcid.GadoxeticAcid .Pharmacolibrary.Drugs.V_Various.V08C_MagneticResonanceImagingContrastMedia.V08CA10_GadoxeticAcid.GadoxeticAcid| name: | GadoxeticAcid | |
| ATC code: | V08CA10 | |
| route: | intravenous | |
| compartments: | 2 | |
| dosage: | 25 | mg |
| volume of distribution: | 0.21 | L |
| clearance: | 3.7 | mL/min/kg |
| other parameters in model implementation | ||
Gadoxetic acid (also known as gadoxetate disodium) is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI), particularly for hepatic (liver) imaging to detect and characterize focal liver lesions. It is approved for clinical use in many countries.
Pharmacokinetic parameters reported in healthy adult volunteers following intravenous administration.